University of California San Francisco

Recalcitrant verruca vulgaris regression following severe SARS-CoV-2 infection.

Barzallo D, Kusari A, Leslie KS PMID: 35966354

A critical review of halobetasol propionate foam (0.05%) as a treatment option for adolescent plaque psoriasis.

Chung M, Yeroushalmi S, Hakimi M, Bartholomew E, Liao W, Bhutani T PMID: 35930002

Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC.

Olsen EA, Whittaker S, Willemze R, Pinter-Brown L, Foss F, Geskin L, Schwartz L, Horwitz S, Guitart J, Zic J, Kim YH, Wood GS, Duvic M, Ai W, Girardi M, Gru A, Guenova E, Hodak E, Hoppe R, Kempf W, Kim E, Lechowicz MJ, Ortiz-Romero P, Papadavid E, Quaglino P, Pittelkow M, Prince HM, Sanches JA, Sugaya M, Vermeer M, Zain J, Knobler R, Stadler R, Bagot M, Scarisbrick J PMID: 34758074

Association of a Dominant T-Cell Clone in Peripheral Blood With Time to Systemic Treatment in Patients With Stage IB Mycosis Fungoides.

Raychaudhuri S, Charli-Joseph Y, Huang CY, Mintz MA, Pincus LB, Ai WZ PMID: 35731525

509 A single-cell transcriptional gradient in human cutaneous memory T cells suppresses pathogenic Th17 inflammation.

M. Taylor, C. Cook, Y. Liu, R. Schmidt, A. Hailer, J. North, H. Wang, S. Kashem, E. Purdom, A. Marson, S. Ramos, R. Cho, J. Cheng PMID:

Generalized Pustular Psoriasis: A Review of the Pathophysiology, Clinical Manifestations, Diagnosis, and Treatment.

Reynolds KA, Pithadia DJ, Lee EB, Clarey D, Liao W, Wu JJ PMID: 36219603

Association of a Dominant T-Cell Clone in Peripheral Blood With Time to Systemic Treatment in Patients With Stage IB Mycosis Fungoides.

Raychaudhuri S, Charli-Joseph Y, Huang CY, Mintz MA, Pincus LB, Ai WZ PMID: 35731525

862 RashX: Immune single-cell transcriptional classification of human chronic inflammatory skin disease.

A. Hailer, Y. Liu, H. Wang, M. Taylor, C. Cook, J. North, T. Mauro, E. Purdom, J. Cheng, R. Cho PMID:

846 A new case series of olmsted syndrome subjects confirms EGFR activation and long term efficacity of oral erlotinib with acceptable tolerance.

J. Basset, Y. Diab, F. Santiago, L. Azulay, K. Cordoro, A. Zhang, F. Watanabe, A. Kirkorian, F. Frascari, D. Siegel, E. Bourrat, R. Howard, A. Hovnanian PMID:

326 High patient acceptability of social needs screening in dermatology clinic.

K. Wilkerson, J.C. Williams, E. De Marchis, N. Rudd, E. Amerson, A. Chang PMID: